
PLRX P/E Ratio
P/E Ratio as of Jun 13, 2025: -0.38
Average-0.3971
Median-0.3800
Minimum-0.4600
Maximum-0.3500
-0.38
Past Month0.00 (0.00%)
The P/E ratio for PLRX is -0.38 as of Jun 13, 2025. This represents a decrease of -86.62% compared to its 12-month average P/E ratio of -2.84. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Pliant Therapeutics P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Pliant Therapeutics’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Pliant Therapeutics to industry peers.
Pliant Therapeutics P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Pliant Therapeutics’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Pliant Therapeutics to industry peers.
PLRX P/E Ratio Insights
See Pliant Therapeutics’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in PLRX
Order type
Buy in
Order amount
Est. shares
0 shares
PLRX P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jun 2, 2025 | $1.44 | -0.40 |
May 1, 2025 | $1.62 | -0.47 |
Apr 1, 2025 | $1.37 | -0.39 |
Mar 3, 2025 | $1.38 | -0.40 |
Feb 3, 2025 | $11.18 | -3.34 |
Jan 2, 2025 | $13.28 | -3.97 |
PLRX End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -0.38 | -90.36% |
2024 | -3.94 | -39.57% |
2023 | -6.52 | -1.21% |
2022 | -6.60 | +32.80% |
2021 | -4.97 | -47.74% |
2020 | -9.51 | — |
FAQs About Pliant Therapeutics (PLRX) P/E ratio
The latest P/E ratio of PLRX is -0.38, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Pliant Therapeutics’s last 12-month average P/E ratio is -2.84, compared to its current P/E ratio of -0.38. This reflects a decrease of -86.62%.
Pliant Therapeutics’s current P/E ratio of -0.38 is lower than its last 12-month average P/E of -2.84. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Pliant Therapeutics’s average P/E ratio over the last 3 years is -5.34. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Pliant Therapeutics’s average P/E ratio over the last 5 years is -5.65. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.